Pdt Partners, LLC Atara Biotherapeutics, Inc. Transaction History

Pdt Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $173,670 - $364,375	-37,030 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $686,762 - $1.37 Million	-81,370 Reduced 68.72%	37,030 $344,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $289,590 - $391,833	19,700 Added 19.96%	118,400 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $11,282 - $16,843	941 Added 0.96%	98,700 $1.77 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $592,166 - $761,685	-45,940 Reduced 31.97%	97,759 $1.52 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $353,416 - $523,055	25,244 Added 21.31%	143,699 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $119,668 - $247,742	-9,445 Reduced 7.38%	118,455 $2.33 Million
Q3 2020 Nov 16, 2020	SELL	$11.92 - $15.87 $303,876 - $404,573	-25,493 Reduced 16.62%	127,900 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $344,121 - $682,301	45,700 Added 42.44%	153,393 $2.24 Million
Q1 2020 May 15, 2020	BUY	$5.69 - $17.78 $33,423 - $104,439	5,874 Added 5.77%	107,693 $916,000
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $754,862 - $1.16 Million	69,317 Added 213.27%	101,819 $1.68 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $390,999 - $648,089	32,502 New	32,502 $459,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.